Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis

Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis

IntroductionDysbiotic gut microbiota (GM) plays a regulatory role during the pathogenesis of several cardiovascular diseases, including atherosclerosis. GM-derived metabolite phenylacetylglutamine (PAGln) enhances platelet responsiveness and thrombosis potential, thereby inducing major adverse cardi...

Full description

Bibliographic Details
Main Authors: Chen Fang, Kun Zuo, Yuan Fu, Jing Li, Hongjiang Wang, Li Xu, Xinchun Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
in-stent stenosis
gut microbiota
phenylacetylglutamine
16S rRNA
coronary artery disease
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.832092/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.832092/full

Similar Items